The increased levels of caspase-1 and IL-1β exhibited by ART-treated HIV-infected adults with HIV viral suppression (without coinfections) may contribute to noncommunicable diseases risk among ART-treated adults with chronic immune activation among adults aging with HIV [24–26]. The gene discussed is CASP1; the disease is coinfection.